DuPont Pharmaceuticals names international EVP

Article

David S. Block, M.D., has been appointed executive vice president of international operations at DuPont Pharmaceuticals. Previously, Block served as senior vice president of business development and strategic planning. In his new role, he will have

David S. Block, M.D., has been appointed executive vice president of international operations at DuPont Pharmaceuticals. Previously, Block served as senior vice president of business development and strategic planning. In his new role, he will have responsibility for profit and loss in all regions outside the U.S. and will be charged with growing these businesses. Block joined the company in 1990 as a product development manager for central nervous system products. He is also an assistant professor of medicine at Johns Hopkins Hospital in Baltimore and a member of the active attending staff in the Moore Clinic for HIV patients.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.